Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis E Hruby

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|May 31, 2012
Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secYKelsi M Sandoz, Steven G Eriksen, Brendan M Jeffrey, et al.
Expert Review of Anti-Infective Therapy|September 4, 2020
An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applicationsAndrew T Russo, Douglas W Grosenbach, Jarasvech Chinsangaram, et al.
The New England Journal of Medicine|July 5, 2018
Oral Tecovirimat for the Treatment of SmallpoxDouglas W Grosenbach, Kady Honeychurch, Eric A Rose, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole and related heterocyclesJames R Burgeson, Amy L Moore, Dima N Gharaibeh, et al.
Infection and Immunity|December 22, 2005
Listeria monocytogenes 10403S HtrA is necessary for resistance to cellular stress and virulenceRebecca L Wilson, Lindsay L Brown, Dana Kirkwood-Watts, et al.
Journal of Virology|June 24, 2011
Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virusScott K Smith, Josh Self, Sonja Weiss, et al.
Vaccine|May 16, 2002
Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectorsChelsea M Byrd, Tove' C Bolken, Kevin F Jones, et al.
Infection and Immunity|April 16, 2002
Analysis of factors affecting surface expression and immunogenicity of recombinant proteins expressed by gram-positive commensal vectorsTové C Bolken, Christine A Franke, Kevin F Jones, et al.
Antimicrobial Agents and Chemotherapy|March 5, 2008
Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitorRobert Jordan, Deborah Tien, Tove' C Bolken, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazoleDongcheng Dai, James R Burgeson, Dima N Gharaibeh, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|May 31, 2012
Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secYKelsi M Sandoz, Steven G Eriksen, Brendan M Jeffrey, et al.
Expert Review of Anti-Infective Therapy|September 4, 2020
An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applicationsAndrew T Russo, Douglas W Grosenbach, Jarasvech Chinsangaram, et al.
The New England Journal of Medicine|July 5, 2018
Oral Tecovirimat for the Treatment of SmallpoxDouglas W Grosenbach, Kady Honeychurch, Eric A Rose, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole and related heterocyclesJames R Burgeson, Amy L Moore, Dima N Gharaibeh, et al.
Infection and Immunity|December 22, 2005
Listeria monocytogenes 10403S HtrA is necessary for resistance to cellular stress and virulenceRebecca L Wilson, Lindsay L Brown, Dana Kirkwood-Watts, et al.
Journal of Virology|June 24, 2011
Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virusScott K Smith, Josh Self, Sonja Weiss, et al.
Vaccine|May 16, 2002
Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectorsChelsea M Byrd, Tove' C Bolken, Kevin F Jones, et al.
Infection and Immunity|April 16, 2002
Analysis of factors affecting surface expression and immunogenicity of recombinant proteins expressed by gram-positive commensal vectorsTové C Bolken, Christine A Franke, Kevin F Jones, et al.
Antimicrobial Agents and Chemotherapy|March 5, 2008
Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitorRobert Jordan, Deborah Tien, Tove' C Bolken, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazoleDongcheng Dai, James R Burgeson, Dima N Gharaibeh, et al.
Pageof 9